Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  
  Current Medicinal Chemistry-Anti-Cancer Agents
ISSN: 1568-0118
  < Previous Issue | Next Issue > | All Issues   |   All Titles
Volume 3
  Issue 5
  Preface [ Hot Topic: Radiation Oncology as Mainstay of Modern Cancer Medicine (Guest Editors: Claus Belka & Verena Jendrossek)]
    pp.ii-ii (1) Authors: Claus Belka, Verena Jendrossek
  Disruption of Cell Death Signaling in Cancer: Impact on Disease Prognosis and Response to Therapy
    pp.319-326 (8) Authors: Dilek Guner, Claus Belka, Peter T. Daniel
  Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action
    pp.327-333 (7) Author: G. Lammering
  Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
    pp.334-342 (9) Authors: Patrizia Marini, Claus Belka
  Membrane Targeted Anticancer Drugs: Potent Inducers of Apoptosis and Putative Radiosensitisers
    pp.343-353 (11) Authors: V. Jendrossek, R. Handrick
  New Targets for the Modulation of Radiation Response - Selective Inhibition of the Enzyme Cyclooxygenase 2
    pp.354-359 (6) Authors: Cordula Petersen, Michael Baumann, Sven Petersen
  Radioprotection of Normal Tissue to Improve Radiotherapy: The Effect of the Bowman Birk Protease Inhibitor
    pp.360-363 (4) Authors: K. H. Dittmann, C. Mayer, H. P. Rodemann
  Hypoxic Radiosensitizers and Hypoxic Cytotoxins in Radiation Oncology
    pp.364-374 (11) Authors: Martin Weinmann, Stefan Welz, Michael Bamberg
  Antiangiogenesis and Radiotherapy: What Is the Role of Combined Modality Treatment?
    pp.375-382 (8) Authors: Johannes Classen, Wilfried Budach
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers